Article ID Journal Published Year Pages File Type
4004950 American Journal of Ophthalmology 2008 5 Pages PDF
Abstract
Intravitreal bevacizumab therapy produced an improvement in foveal thickness over time in eyes with neovascular AMD when one injection was given each month for three consecutive months. All eyes experienced increased foveal thickening during the subsequent three months without treatment.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Preview
Treatment of Neovascular Age-related Macular Degeneration with Intravitreal Bevacizumab: Efficacy of Three Consecutive Monthly Injections
Authors
, , ,